Off-label Drug Marketing of Antipsychotic Drugs for Children?

prescription drug fraud 300x218 Off label Drug Marketing of Antipsychotic Drugs for Children?A new study found a 62% increase in the number of children ages 3 to 18 who are enrolled in Medicaid taking antipsychotic drugs in the last ten years.  The number of children taking such antipsychotics was 354,000 in 2007.  Science Daily reports:

Increased antipsychotic use was observed across a wide range of mental health diagnoses, and was particularly high for children with ADHD or conduct disorder, although the FDA has not approved the drugs to treat these conditions in children. In total, 65% of children prescribed antipsychotics in 2007 were using the drugs “off-label,” or without FDA safety and efficacy data to support their use to treat young patients…

The frequent off-label use of antipsychotics has raised concern among many health care providers, especially in light of evidence linking antipsychotics with an increased risk of serious metabolic side effects in children, including weight gain and diabetes.

While it is not illegal for doctors to prescribe drugs for uses not approved by the FDA, off-label drug marketing by pharmaceutical companies is illegal.  If you have non-public information about off-label pharmaceutical marketing or other pharmaceutical fraud, a whistleblower attorney can help you determine whether you have a case and can guide you through the steps that need to be taken.  Call 1-877-255-2676 today or contact us.

 

No Comments

Trackbacks/Pingbacks

  1. Abbott Labs Fined $700M for Off Label Marketing - Medicare Whistleblower Rights - [...] to be a disturbing trend of off label marketing to children, especially children with ADD, see Off-label Drug Marketing …

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Facebook